Author:
Su Ying-Fang,Wu Tzu-Fan,Ko Jiunn-Liang,Tsai Hsiu-Ting,Tee Yi-Torng,Chien Ming-Hsien,Chou Chi-Hung,Lin Wea-Lung,Low Hui-Ying,Chou Ming-Yung,Yang Shun-Fa,Wang Po-Hui
Publisher
Public Library of Science (PLoS)
Reference40 articles.
1. Ribonucleotide reductase inhibitors and future drug design;J Shao;Curr Cancer Drug Targets,2006
2. Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair;V D'Angiolella;Cell,2012
3. Ribonucleotide reductase inhibitors: new strategies for cancer chemotherapy;G Nocentini;Crit Rev Oncol Hematol,1996
4. Ribonucleotide reductase subunit one as gene therapy target: commentary re: M-Y. Cao et al., Adenovirus-mediated ribonucleotide reductase R1 gene therapy of human colon adenocarcinoma;Y Yen;Clin Cancer Res,2003
5. The structural basis for the allosteric regulation of ribonucleotide reductase;MF Ahmad;Prog Mol Biol Transl Sci,2013
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献